These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8441917)

  • 1. Pancreatic gangliosides delay the onset of insulitis and hyperglycaemia in the low-dose streptozotocin mouse model.
    Anastasi E; Tiberti C; Sensi M; Ponte E; Filippetti R; Dotta F; Vecci E; Fiori MG; Di Mario U
    Scand J Immunol; 1993 Mar; 37(3):308-13. PubMed ID: 8441917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin model.
    Zielasek J; Kolb H
    Life Sci; 1992; 51(1):49-52. PubMed ID: 1535407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.
    Sandler S
    Diabetologia; 1984 May; 26(5):386-8. PubMed ID: 6234194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides prevent insulitis but not islet B cell destruction in low-dose streptozocin-treated mice.
    Papaccio G
    Diabetes Res Clin Pract; 1993 Jan; 19(1):9-15. PubMed ID: 8472624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro.
    Saï P; Pogu S; Ouary M
    Diabetologia; 1991 Apr; 34(4):212-7. PubMed ID: 2065856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal co-administration of thymosin alpha-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice.
    Qiu L; Zhang C; Zhang J; Liang J; Liu J; Ji C; Yang JY
    Int J Mol Med; 2009 May; 23(5):597-602. PubMed ID: 19360317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific loss of C-series gangliosides in pancreas of streptozotocin-induced diabetic rats.
    Saito M; Ito M; Sugiyama K
    Life Sci; 1999; 64(20):1803-10. PubMed ID: 10350354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial protection against streptozotocin-induced hyperglycaemia by superoxide dismutase linked to polyethylene glycol.
    Asplund K; Grankvist K; Marklund S; Täljedal IB
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):390-4. PubMed ID: 6239493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P preserves pancreatic β-cells in streptozotocin-induced type 1 diabetic mice.
    Jung N; Um J; Kim DY; Dubon MJ; Byeon Y; Kim D; Son Y; Park KS
    Biochem Biophys Res Commun; 2017 Sep; 491(4):958-965. PubMed ID: 28754588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes.
    Li B; Luo C; Chowdhury S; Gao ZH; Liu JL
    Regul Pept; 2013 Sep; 186():83-91. PubMed ID: 23954400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice.
    Holstad M; Sandler S
    J Autoimmun; 2001 Jun; 16(4):441-7. PubMed ID: 11437492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats.
    Ralevic V; Belai A; Burnstock G
    Br J Pharmacol; 1993 Nov; 110(3):1105-11. PubMed ID: 8298799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet implantation normalises hyperglycaemia caused by streptozotocin-induced insulitis. Experiments in mice.
    Andersson A
    Lancet; 1979 Mar; 1(8116):581-4. PubMed ID: 85167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.
    Sandler S; Andersson A
    Diabetologia; 1982 Oct; 23(4):374-8. PubMed ID: 6292033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
    Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
    Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.